In 2016, recent research conducted by Désirée Schönenberger and colleagues revealed ... experimentally demonstrated that loss of either HIF1α or HIF2α in a Vhl/Trp53-deficient mouse model inhibited tumor formation, suggesting that both are required for tumor initiation in this system (45). Here, TP53 is linked to neoplasm.